FDA inspection
Milestone Pharmaceutiques Inc.: FDA inspection ending Nov 19, 2024
FDA inspection 1254829 · Voluntary Action Indicated (VAI) · Saint-Laurent
Key facts
| Inspection ID | 1254829 |
|---|---|
| Firm | Milestone Pharmaceutiques Inc. |
| FEI number | 3031306324 |
| Address | 1111 Dr.-Frederik-Philips Blvd Suite 420 |
| City | Saint-Laurent |
| Country | Canada |
| Fiscal year | 2025 |
| Inspection end date | Nov 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data